On-Going Pharmacovigilance Projects

TMDA is currently implementing two (2) Projects called PROFORMA and PAVIA funded by European Union’s Framework Programme for Research and Innovation Horizon 2020 via the European and Developing Countries Clinical Trials Partnership Association (EDCTP2).

PROFORMA stands for Pharmacovigilance infrastructure and post-marketing surveillance system capacity building for regional medicine regulatory harmonization in East Africa. It is a consortium between academia and regulatory authorities from four (4) African countries; Ethiopia, Kenya, Tanzania, and Rwanda and other international collaborators including Karolinska Institutet (Sweden) and WHO collaborating Centre’s in Pharmacovigilance Centre-Lareb, Netherland. For more information about PROFORMA Project please follow this link.

PAVIA stands for Pharmacovigilance Africa and is a consortium between research institutions and regulatory authorities from four (4) African countries; Ethiopia, Eswatiin, Tanzania, and Nigeria and other international collaborators including University of Verona (Italy) and Amsterdam Institute for Global Health Development (AIGHD), Netherland. For more information about PAVIA Project please follow the link.